An unusual white blood cell count can be a sign of chronic myeloid leukemia (CML), a type of blood cancer. CML can affect the balance of white blood cells in the blood and cause them to function ...

Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. In this type of cancer, the bone marrow produces too many white blood cells. If the disease isn’t effectively treated, it ...

Chronic myeloid leukemia (CML) blast crisis phase is the last stage of the condition where there are large clusters of immature white blood cells, or blasts, in the bone marrow, organs, and tissue.

Experts on chronic myeloid leukemia discuss how caregivers can collaborate with the health care team and support newly diagnosed patients. In your work with caregivers, how have you seen them ...

Articles published in this focus collection were selected from recent issues of Leukemia. They highlight new developments in our understanding and management of persons with CML. CML was the first ...

Chronic myeloid leukemia (CML) is a chronic type of leukemia. It’s also called chronic myelogenous leukemia. CML occurs when an abnormal gene allows cancer to spread in your body. Researchers have ...

Chronic myeloid leukemia (CML) is highly treatable. With an experienced care team, most people do well for many years on medicines they take at home. At Fred Hutch Cancer Center, our CML experts ...

The FDA granted breakthrough therapy designation to TERN-701 for adults with Philadelphia chromosome-positive CML without the ...

With today’s medicines, most people with chronic myeloid leukemia (CML) have a normal lifespan and a good quality of life. The key is to get care from CML experts — like the physicians at Fred ...

For the 10–15% of patients with chronic phase CML unable to achieve an adequate response with a tolerable dose of TKI, allogeneic HSCT offers a feasible alternative strategy Early assessment ...